TU Teaching Hospital
Welcome,         Profile    Billing    Logout  
 0 Trials 
3 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Das, Santa K
NCT05501522: Immunogenicity and Safety Study of Heterologous Booster Vaccination of a SARS-CoV-2 Recombinant Protein Nanoparticle Vaccine(GBP510) Adjuvanted with AS03 in Adults Aged 18 Years and Older

Completed
3
840
RoW
GBP510 adjuvanted with AS03, Placebo (Normal Saline)
SK Bioscience Co., Ltd., Coalition for Epidemic Preparedness Innovations, International Vaccine Institute, GlaxoSmithKline
COVID-19
08/23
08/24
NCT05710289: A Blood Collection Study to Assess the Immunogenicity of Nationally Authorized Homologous COVID-19 Booster Vaccines Among Adult Vaccinees.

Withdrawn
N/A
720
NA
Immune Responses
SK Bioscience Co., Ltd., International Vaccine Institute
COVID-19
02/24
02/24
CPT-R-Nepal, NCT04570982: Clinical Protocol for Convalescent Plasma and Remdesivir Therapy in Nepal

Recruiting
N/A
200
RoW
Convalescent Plasma
Dr. Pradip Gyanwali,MD, Ministry of Health and Population, Nepal
COVID-19
10/20
12/20

Download Options